Germany’s Merck KGaA is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical ...
The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...
The drug company’s outlook for 2025 and a slide in sales of its HPV vaccine, Gardasil, hit shares.
Merck swung to a fourth-quarter profit as sales grew and even exceeded Wall Street’s estimates, boosted in part by the performance of top asset Keytruda. The drug company logged net income of $3 ...
Merck swung to a quarterly profit as sales grew to beat Wall Street’s estimates, though the drug company’s outlook for 2025 and a slide in sales of its HPV vaccine, Gardasil, hit shares. The ...
Merck swung to a fourth-quarter profit as sales grew and even exceeded Wall Street’s estimates, boosted in part by the performance of top asset Keytruda.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results